About Cleargreens Pharmaceuticals
Cleargreens Pharmaceuticals is a company based in India by Pravin Navle, Chetan Majmudar, and Ramesh Kalavadia. It operates as a B2B. Cleargreens Pharmaceuticals offers products and services including API Products, Regulatory Support, and Trading Services. Cleargreens Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter India
- Founders Pravin Navle, Chetan Majmudar, Ramesh Kalavadia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Cleargreens Pharmaceuticals Private Limited
- Date of Incorporation 05 Apr, 2017
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$5.14 M (USD)10.49as on Mar 31, 2022
-
Net Profit
$363.2 K (USD)3.35as on Mar 31, 2022
-
EBITDA
$526.74 K (USD)4.72as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cleargreens Pharmaceuticals
Cleargreens Pharmaceuticals offers a comprehensive portfolio of products and services, including API Products, Regulatory Support, and Trading Services.
Develops and markets niche APIs for generic and import substitution needs.
Offers DMF support for API compliance and regulatory requirements.
Facilitates sourcing of packaging materials and APIs at lower costs.
Funding Insights of Cleargreens Pharmaceuticals
Detailed funding history for Cleargreens Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cleargreens Pharmaceuticals
Investment portfolio details for Cleargreens Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cleargreens Pharmaceuticals
Detailed financials for Cleargreens Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cleargreens Pharmaceuticals Comparisons
Peer comparison for Cleargreens Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cleargreens Pharmaceuticals
Cleargreens Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Cleargreens Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cleargreens Pharmaceuticals
Complete news archive for Cleargreens Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cleargreens Pharmaceuticals
Cleargreens Pharmaceuticals is headquartered in India.
Annual revenue of Cleargreens Pharmaceuticals is $5.14M as on Mar 31, 2022.
Cleargreens Pharmaceuticals Pvt. Ltd. focuses on developing and marketing niche Active Pharmaceutical Ingredients (APIs) with non-infringing routes. They provide comprehensive regulatory support through Drug Master Files (DMF) and assist with import substitutions. Based in Ahmedabad, India, they work closely with clients seeking cost-effective sourcing and compliance. Their trading services connect suppliers and customers for primary packaging materials and APIs.
Cleargreens Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Cleargreens Pharmaceuticals offers API Products, Regulatory Support, and Trading Services.